title: The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism.
authors: Institut de Chimie Thérapeutique, Ecole de Pharmacie Université de Lausanne, Switzerland.
authors: G
authors: G
authors: Maret
authors: B
authors: B
authors: Testa
authors: P
authors: P
authors: Jenner
authors: N
authors: N
authors: el Tayar
authors: P A
authors: PA
authors: Carrupt
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000009:adverse effects*; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D008995:Monoamine Oxidase / Q000378:metabolism*; D009498:Neurotoxins / Q000378:metabolism; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*
chemical_list: D009498:Neurotoxins; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D008995:Monoamine Oxidase